Press Release
King's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumoursCell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platformStratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining high